Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates - PubMed (original) (raw)
Drug efficiency: a new concept to guide lead optimization programs towards the selection of better clinical candidates
Simone Braggio et al. Expert Opin Drug Discov. 2010 Jul.
Abstract
As a result of their wide acceptance and conceptual simplicity, drug-like concepts are having a major influence on the drug discovery process, particularly in the selection of the 'optimal' absorption, distribution, metabolism, excretion and toxicity and physicochemical parameters space. While they have an undisputable value when assessing the potential of lead series or in evaluating inherent risk of a portfolio of drug candidates, they result much less useful in weighing up compounds for the selection of the best potential clinical candidate. We introduce the concept of drug efficiency as a new tool both to guide the drug discovery program teams during the lead optimization phase and to better assess the developability potential of a drug candidate.
Similar articles
- Improving drug candidates by design: a focus on physicochemical properties as a means of improving compound disposition and safety.
Meanwell NA. Meanwell NA. Chem Res Toxicol. 2011 Sep 19;24(9):1420-56. doi: 10.1021/tx200211v. Epub 2011 Jul 26. Chem Res Toxicol. 2011. PMID: 21790149 Review. - Applications of high-throughput ADME in drug discovery.
Kassel DB. Kassel DB. Curr Opin Chem Biol. 2004 Jun;8(3):339-45. doi: 10.1016/j.cbpa.2004.04.015. Curr Opin Chem Biol. 2004. PMID: 15183334 Review. - Ligand efficiency indices for effective drug discovery.
Abad-Zapatero C. Abad-Zapatero C. Expert Opin Drug Discov. 2007 Apr;2(4):469-88. doi: 10.1517/17460441.2.4.469. Expert Opin Drug Discov. 2007. PMID: 23484756 - Application of drug efficiency index in drug discovery: a strategy towards low therapeutic dose.
Montanari D, Chiarparin E, Gleeson MP, Braggio S, Longhi R, Valko K, Rossi T. Montanari D, et al. Expert Opin Drug Discov. 2011 Sep;6(9):913-20. doi: 10.1517/17460441.2011.602968. Epub 2011 Jul 22. Expert Opin Drug Discov. 2011. PMID: 22646214
Cited by
- Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
Hann MM, Keserü GM. Hann MM, et al. Nat Rev Drug Discov. 2012 Apr 30;11(5):355-65. doi: 10.1038/nrd3701. Nat Rev Drug Discov. 2012. PMID: 22543468 Review. - A simple model to solve a complex drug toxicity problem.
Dixit VA. Dixit VA. Toxicol Res (Camb). 2018 Nov 29;8(2):157-171. doi: 10.1039/c8tx00261d. eCollection 2019 Mar 1. Toxicol Res (Camb). 2018. PMID: 30997019 Free PMC article. - Treatment With Nepicastat Decreases Contextual Traumatic Memories Persistence in Post-traumatic Stress Disorder.
Martinho R, Correia G, Seixas R, Oliveira A, Silva S, Serrão P, Fernandes-Lopes C, Costa C, Moreira-Rodrigues M. Martinho R, et al. Front Mol Neurosci. 2021 Sep 24;14:745219. doi: 10.3389/fnmol.2021.745219. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34630037 Free PMC article. - In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis.
Marquês JT, Frazão De Faria C, Reis M, Machado D, Santos S, Santos MDS, Viveiros M, Martins F, De Almeida RFM. Marquês JT, et al. Front Pharmacol. 2022 May 4;13:868545. doi: 10.3389/fphar.2022.868545. eCollection 2022. Front Pharmacol. 2022. PMID: 35600870 Free PMC article.
LinkOut - more resources
Full Text Sources
Research Materials